On March 5, 2018 Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, reported that Chip Clark, president and chief executive officer, will present a corporate overview at two upcoming investor conferences (Press release, Genocea Biosciences, MAR 5, 2018, View Source [SID1234524368]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

and Company 38th Annual Health Care Conference
Monday, March 12, 2018Cowen at 11:20 AM ET in Boston, Massachusetts
Needham & Co. Annual Healthcare Conference
Tuesday, March 27, 2018 at 10:30 AM ET in New York, New York

A live webcast of both presentations can be accessed by visiting the "Events and Presentations" tab of the investor relations section of the Genocea website at View Source A replay of the webcasts will be archived for 30 days following the conference.